Replies to post #238203 on Biotech Values

[gfp927z]

Dew, I was wondering if you have any opinions on the emerging psychedelic medicine area? There is a new ETF covering the sector which became available in the US last week (Defiance Next Gen Altered Experience ETF (PSY), and an upcoming IPO of a Peter Thiel backed company (ATAI Life Sciences), which should generate investor interest in the sector. The FDA approved Spravato in 2019 (mirror isomer of Ketamine) for treatment resistant depression, and there appears to be a lot of research activity in this sector.

Thanks for any opinions/insights from you and your Biotech Values board members :o)

I have some articles and related stock lists here -

https://investorshub.advfn.com/Psychedelic-Medicine-Sector-37972/